Diversity in clinical trials is so important to me because inclusion truly matters. The chemo that saved my life would not be appropriate to use in me if it had not been tested in someone like me. With so much diversity across populations, clinical trials must be appropriately inclusive of racial and ethnic minority groups, as well as other populations experiencing health disparities, including sexual and gender minority or socioeconomically disadvantaged populations. People can experience the same disease very differently. It’s important that clinical trials include people with different lived experiences, as well as characteristics like race and ethnicity, age, sex, and sexual orientation, so that all communities benefit from scientific advances and treatments.